Quantitative analysis for Sangamo Therapeutics, Inc. (SGMO) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Sell (43.0) (grade D).
SGMO stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-03-19 | $0.37 | $0.34 | $0.34 |
| 2026-03-31 | $0.25 | $0.20 | $0.25 |
| 2026-04-13 | $0.27 | $0.25 | $0.26 |
| 2026-04-23 | $0.26 | $0.25 | $0.26 |
| 2026-05-05 | $0.20 | $0.11 | $0.11 |
| 2026-05-15 | $0.14 | $0.12 | $0.14 |
| 2026-05-28 | $0.21 | $0.19 | $0.21 |
| 2026-06-09 | $0.19 | $0.13 | $0.15 |
| 2026-06-22 | $0.18 | $0.17 | $0.17 |
| 2026-07-02 | $0.08 | $0.05 | $0.07 |
| 2026-07-15 | $0.08 | $0.07 | $0.07 |
| 2026-07-27 | $0.07 | $0.06 | $0.06 |
How Sangamo Therapeutics, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| GUTS | Fractyl Health, Inc. Common Stock | $67M | — |
| INO | Inovio Pharmaceuticals, Inc. | $66M | — |
| XTNT | Xtant Medical Holdings, Inc. | $65M | — |
| CBUS | Cibus, Inc. | $65M | — |
View all Health Care stocks by valuation and signals →
Sangamo Therapeutics, Inc. (SGMO) scores Sell (43.0), and the composite conceals a 72-point disagreement between its dimensions. It is strongest on analyst consensus at 74, and weakest on technicals at 2. A stock can carry analyst consensus that high while technicals sits at 2; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 74 |
| technicals | 2 |
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Sangamo Therapeutics, Inc. (SGMO): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/SGMO"><img src="https://stoquant.com/badge/SGMO.svg" alt="Sangamo Therapeutics, Inc. (SGMO) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.